WeMake delivers strategic advisory across six high-impact technology areas.
Strategic consulting for biologic drug development—from target validation and CMC strategy through IND/BLA preparation, manufacturing partnerships, and global regulatory submissions. Our team has supported 100+ submissions to FDA, EMA, MHRA, and other agencies.
CRO & Clinical Consulting
Advisory on next-generation propulsion systems including materials selection, thermal management, systems integration, test-stand design, and technology readiness level (TRL) assessment for aerospace, defense, and advanced mobility applications.
Email Us
We help organizations adopt AI safely and productively—covering use-case identification, model selection, data governance, MLOps infrastructure, workflow integration, and change management for enterprise and industrial deployments.
Email Us
End-to-end robotics consulting including feasibility studies, system architecture, vendor selection, deployment planning, human-robot interaction design, and operational optimization for commercial and research environments.
A.I. Barista Robot
Consulting on brain-computer interfaces, neurostimulation devices, wearable sensing platforms, cognitive assessment protocols (including MoCA), and FDA/IDE regulatory pathways for neuromodulation and neuropsychiatric trials.
Email Us
Advisory on regenerative medicine program design, cell therapy partnerships, site and lab infrastructure, patient recruitment strategy, long-term follow-up planning, and commercialization pathways for advanced therapeutic products.
Super Nova MSCsWithin our biotherapeutics practice, WeMake offers full-service Clinical Research Organization (CRO) and Site Management Organization (SMO) capabilities. With 700+ studies delivered, 200+ collaborating sites, and expertise across EDC platforms, biostatistics, and global regulatory submissions, we support sponsors from pre-IND through database lock.